Follow the people · Insider
Jeffrey B. Kindler
Jeffrey B. Kindler files insider transactions with the SEC as a director of Precigen (PGEN). We hold 1 disclosed purchase or sale filed since 4 January 2006, 1 of them in the last 90 days.
- Files forPGEN
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure28 August 2026
Positions held
10 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 8 March 2020 — 26 August 2026Director · Precigen (PGEN)46 Form 4 lines · source: SEC Form 4
- Filed 6 February 2026 — 10 June 2026Director · Praxis Precision Medicines (PRAX)8 Form 4 lines · source: SEC Form 4
- Filed 28 September 2021 — 5 May 2026Director · Terns Pharmaceuticals (TERN)18 Form 4 lines · source: SEC Form 4
- Filed 6 June 2017 — 14 May 2025Director · PERRIGO Co (PRGO)38 Form 4 lines · source: SEC Form 4
- Filed 10 February 2020 — 8 December 2021Director · Ppd (PPD)9 Form 4 lines · source: SEC Form 4
- Filed 4 August 2015 — 11 June 2020Executive Chairman · vTv Therapeutics (VTVT)10 Form 4 lines · source: SEC Form 4
- Filed 21 March 2013 — 21 May 2020Director · Siga Technologies (SIGA)23 Form 4 lines · source: SEC Form 4
- Filed 13 August 2013 — 23 March 2019Director · Intrexon (XON)30 Form 4 lines · source: SEC Form 4
- Filed 3 December 2012 — 15 May 2014Director · Chipotle Mexican Grill (CMG)5 Form 4 lines · source: SEC Form 4
- Filed 30 December 2005 — 15 December 2010Former Chairman & CEO · Pfizer (PFE)132 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 185,000 shares of PrecigenSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- was granted 1,371 shares of Praxis Precision MedicinesSEC Form 412 June 2026Common Stock · traded 10 June 2026 · filed 12 June 2026
- was granted 648 shares of Praxis Precision Medicines (a derivative holding)SEC Form 412 June 2026Stock Option (Right to Buy) · traded 10 June 2026 · filed 12 June 2026
- returned to the issuer 32,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- returned to the issuer 45,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- returned to the issuer 10,657 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- returned to the issuer 4,676 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- returned to the issuer 32,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- returned to the issuer 28,475 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- returned to the issuer 22,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- returned to the issuer 32,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- returned to the issuer 1,697 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 45 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- exercised options over 71,839 shares of PrecigenSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- exercised options over 71,839 shares of Precigen (a derivative holding)SEC Form 416 March 2026Restricted Stock Units · traded 13 March 2026 · filed 16 March 2026
- exercised options over 71,839 shares of Precigen (a derivative holding)SEC Form 416 March 2026Restricted Stock Units · traded 13 March 2026 · filed 16 March 2026
- exercised options over 71,839 shares of PrecigenSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- was granted 19,658 shares of PrecigenSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- was granted 35,612 shares of Precigen (a derivative holding)SEC Form 412 March 2026Restricted Stock Units · traded 10 March 2026 · filed 12 March 2026
- was granted 41,073 shares of Precigen (a derivative holding)SEC Form 412 March 2026Option to Purchase Common Stock (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- was granted 35,612 shares of Precigen (a derivative holding)SEC Form 412 March 2026Restricted Stock Units · traded 10 March 2026 · filed 12 March 2026
- was granted 41,073 shares of Precigen (a derivative holding)SEC Form 412 March 2026Option to Purchase Common Stock (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- was granted 19,658 shares of PrecigenSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- was granted 688 shares of Praxis Precision MedicinesSEC Form 410 February 2026Common Stock · traded 6 February 2026 · filed 10 February 2026
- was granted 478 shares of Praxis Precision MedicinesSEC Form 410 February 2026Common Stock · traded 6 February 2026 · filed 10 February 2026
- was granted 224 shares of Praxis Precision Medicines (a derivative holding)SEC Form 410 February 2026Stock Option (Right to Buy) · traded 6 February 2026 · filed 10 February 2026
- was granted 224 shares of Praxis Precision Medicines (a derivative holding)SEC Form 410 February 2026Stock Option (Right to Buy) · traded 6 February 2026 · filed 10 February 2026
- was granted 688 shares of Praxis Precision MedicinesSEC Form 410 February 2026Common Stock · traded 6 February 2026 · filed 10 February 2026
- was granted 478 shares of Praxis Precision MedicinesSEC Form 410 February 2026Common Stock · traded 6 February 2026 · filed 10 February 2026
- was granted 1,697 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 1 February 2026 · filed 2 February 2026
- was granted 1,697 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 1 February 2026 · filed 2 February 2026
- ▼ sold on the open market 235,467 shares of PrecigenSEC Form 416 December 2025Common Stock · traded 12 December 2025 · filed 16 December 2025
- ▼ sold on the open market 67,523 shares of PrecigenSEC Form 41 October 2025Common Stock · traded 29 September 2025 · filed 1 October 2025
- ▼ sold on the open market 106,837 shares of PrecigenSEC Form 41 October 2025Common Stock · traded 30 September 2025 · filed 1 October 2025
- was granted 45,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 412 June 2025Stock Option (Right to Buy) · traded 11 June 2025 · filed 12 June 2025
- was granted 7,305 shares of PERRIGO Co (a derivative holding)SEC Form 416 May 2025Restricted Stock Units · traded 14 May 2025 · filed 16 May 2025
- exercised options over 9,904 shares of PERRIGO Co (a derivative holding)SEC Form 416 May 2025Restricted Stock Units · traded 14 May 2025 · filed 16 May 2025
- exercised options over 9,904 shares of PERRIGO CoSEC Form 416 May 2025Ordinary Shares · traded 14 May 2025 · filed 16 May 2025
- had shares withheld for tax on 4,754 shares of PERRIGO CoSEC Form 416 May 2025Ordinary Shares · traded 14 May 2025 · filed 16 May 2025
- was granted 71,839 shares of Precigen (a derivative holding)SEC Form 417 March 2025Restricted Stock Units · traded 13 March 2025 · filed 17 March 2025
- exercised options over 87,412 shares of Precigen (a derivative holding)SEC Form 417 March 2025Restricted Stock Units · traded 14 March 2025 · filed 17 March 2025
- was granted 83,517 shares of Precigen (a derivative holding)SEC Form 417 March 2025Option to Purchase Common Stock (Right to Buy) · traded 13 March 2025 · filed 17 March 2025
- was granted 39,655 shares of PrecigenSEC Form 417 March 2025Common Stock · traded 13 March 2025 · filed 17 March 2025
- exercised options over 87,412 shares of PrecigenSEC Form 417 March 2025Common Stock · traded 14 March 2025 · filed 17 March 2025
- was granted 10,657 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 43 February 2025Stock Option (Right to Buy) · traded 1 February 2025 · filed 3 February 2025
- ▼ sold on the open market 17,598 shares of PERRIGO CoSEC Form 410 December 2024Ordinary Shares · traded 9 December 2024 · filed 10 December 2024
- was granted 4,676 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 42 July 2024Stock Option (Right to Buy) · traded 1 July 2024 · filed 2 July 2024
- was granted 32,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 414 June 2024Stock Option (Right to Buy) · traded 10 June 2024 · filed 14 June 2024
- was granted 9,904 shares of PERRIGO Co (a derivative holding)SEC Form 416 May 2024Restricted Stock Units · traded 14 May 2024 · filed 16 May 2024
- exercised options over 8,764 shares of PERRIGO Co (a derivative holding)SEC Form 416 May 2024Restricted Stock Units · traded 15 May 2024 · filed 16 May 2024
- exercised options over 8,764 shares of PERRIGO CoSEC Form 416 May 2024Ordinary Shares · traded 15 May 2024 · filed 16 May 2024
- had shares withheld for tax on 4,207 shares of PERRIGO CoSEC Form 416 May 2024Ordinary Shares · traded 15 May 2024 · filed 16 May 2024
- was granted 87,412 shares of Precigen (a derivative holding)SEC Form 418 March 2024Restricted Stock Units · traded 14 March 2024 · filed 18 March 2024
- was granted 101,626 shares of Precigen (a derivative holding)SEC Form 418 March 2024Option to Purchase Common Stock (Right to Buy) · traded 14 March 2024 · filed 18 March 2024
- was granted 48,251 shares of PrecigenSEC Form 418 March 2024Common Stock · traded 14 March 2024 · filed 18 March 2024
- exercised options over 106,837 shares of Precigen (a derivative holding)SEC Form 412 March 2024Restricted Stock Units · traded 9 March 2024 · filed 12 March 2024
- exercised options over 106,837 shares of PrecigenSEC Form 412 March 2024Common Stock · traded 9 March 2024 · filed 12 March 2024
- ▼ sold on the open market 96,686 shares of PrecigenSEC Form 429 December 2023Common Stock · traded 28 December 2023 · filed 29 December 2023
- was granted 32,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 414 June 2023Stock Option (Right to Buy) · traded 12 June 2023 · filed 14 June 2023
- exercised options over 7,778 shares of PERRIGO Co (a derivative holding)SEC Form 419 May 2023Restricted Stock Units · traded 17 May 2023 · filed 19 May 2023
- exercised options over 7,778 shares of PERRIGO CoSEC Form 419 May 2023Ordinary Shares · traded 17 May 2023 · filed 19 May 2023
- had shares withheld for tax on 3,734 shares of PERRIGO CoSEC Form 419 May 2023Ordinary Shares · traded 17 May 2023 · filed 19 May 2023
- was granted 8,764 shares of PERRIGO Co (a derivative holding)SEC Form 417 May 2023Restricted Stock Units · traded 15 May 2023 · filed 17 May 2023
- was granted 106,837 shares of Precigen (a derivative holding)SEC Form 413 March 2023Restricted Stock Units · traded 9 March 2023 · filed 13 March 2023
- was granted 125,489 shares of Precigen (a derivative holding)SEC Form 413 March 2023Option to Purchase Common Stock (Right to Buy) · traded 9 March 2023 · filed 13 March 2023
- was granted 58,974 shares of PrecigenSEC Form 413 March 2023Common Stock · traded 9 March 2023 · filed 13 March 2023
- exercised options over 61,576 shares of Precigen (a derivative holding)SEC Form 424 February 2023Restricted Stock Units · traded 22 February 2023 · filed 24 February 2023
- exercised options over 61,576 shares of PrecigenSEC Form 424 February 2023Common Stock · traded 22 February 2023 · filed 24 February 2023
- ▼ sold on the open market 50,000 shares of PrecigenSEC Form 415 August 2022Common Stock · traded 11 August 2022 · filed 15 August 2022
- was granted 32,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 421 June 2022Stock Option (Right to Buy) · traded 16 June 2022 · filed 21 June 2022
- was granted 7,778 shares of PERRIGO Co (a derivative holding)SEC Form 419 May 2022Restricted Stock Units · traded 17 May 2022 · filed 19 May 2022
- exercised options over 6,599 shares of PERRIGO Co (a derivative holding)SEC Form 419 May 2022Restricted Stock Units · traded 17 May 2022 · filed 19 May 2022
- exercised options over 6,599 shares of PERRIGO CoSEC Form 419 May 2022Ordinary Shares · traded 17 May 2022 · filed 19 May 2022
- had shares withheld for tax on 3,168 shares of PERRIGO CoSEC Form 419 May 2022Ordinary Shares · traded 17 May 2022 · filed 19 May 2022
- exercised options over 16,212 shares of Precigen (a derivative holding)SEC Form 429 March 2022Restricted Stock Units · traded 25 March 2022 · filed 29 March 2022
- exercised options over 16,212 shares of PrecigenSEC Form 429 March 2022Common Stock · traded 25 March 2022 · filed 29 March 2022
- was granted 61,576 shares of Precigen (a derivative holding)SEC Form 424 February 2022Restricted Stock Units · traded 22 February 2022 · filed 24 February 2022
- was granted 83,189 shares of Precigen (a derivative holding)SEC Form 424 February 2022Option to Purchase Common Stock (Right to Buy) · traded 22 February 2022 · filed 24 February 2022
- was granted 33,990 shares of PrecigenSEC Form 424 February 2022Common Stock · traded 22 February 2022 · filed 24 February 2022
- returned to the issuer 99,487 shares of PpdSEC Form 48 December 2021Common Stock · traded 8 December 2021 · filed 8 December 2021
- returned to the issuer 18,500 shares of PpdSEC Form 48 December 2021Common Stock · traded 8 December 2021 · filed 8 December 2021
- was granted 22,000 shares of Terns Pharmaceuticals (a derivative holding)SEC Form 430 September 2021Stock Option (Right to Buy) · traded 28 September 2021 · filed 30 September 2021
- was granted 6,599 shares of PERRIGO Co (a derivative holding)SEC Form 419 May 2021Restricted Stock Units · traded 17 May 2021 · filed 19 May 2021
- exercised options over 5,804 shares of PERRIGO Co (a derivative holding)SEC Form 411 May 2021Restricted Stock Units · traded 7 May 2021 · filed 11 May 2021
- exercised options over 5,804 shares of PERRIGO CoSEC Form 411 May 2021Ordinary Shares · traded 7 May 2021 · filed 11 May 2021
- had shares withheld for tax on 2,786 shares of PERRIGO CoSEC Form 411 May 2021Ordinary Shares · traded 7 May 2021 · filed 11 May 2021
- was granted 2,164 shares of PpdSEC Form 427 April 2021Common Stock · traded 23 April 2021 · filed 27 April 2021
- was granted 8,949 shares of PrecigenSEC Form 429 March 2021Common Stock · traded 25 March 2021 · filed 29 March 2021
- was granted 16,212 shares of Precigen (a derivative holding)SEC Form 429 March 2021Restricted Stock Units · traded 25 March 2021 · filed 29 March 2021
- was granted 22,107 shares of Precigen (a derivative holding)SEC Form 429 March 2021Option to Purchase Common Stock (Right to Buy) · traded 25 March 2021 · filed 29 March 2021
- exercised options over 62,189 shares of PrecigenSEC Form 416 March 2021Common Stock · traded 13 March 2021 · filed 16 March 2021
- exercised options over 62,189 shares of Precigen (a derivative holding)SEC Form 416 March 2021Restricted Stock Units · traded 13 March 2021 · filed 16 March 2021
- gave away 18,500 shares of PpdSEC Form 412 February 2021Common Stock · traded 2 December 2020 · filed 12 February 2021
- gave away 18,500 shares of PpdSEC Form 412 February 2021Common Stock · traded 2 December 2020 · filed 12 February 2021
- was granted 15,000 shares of vTv Therapeutics (a derivative holding)SEC Form 415 June 2020Director stock option (right to buy) · traded 11 June 2020 · filed 15 June 2020
- exercised options over 15,000 shares of Siga Technologies (a derivative holding)SEC Form 422 May 2020Restricted Stock Units · traded 21 May 2020 · filed 22 May 2020
- exercised options over 15,000 shares of Siga TechnologiesSEC Form 422 May 2020Common Stock, Par Value $.0001 Per Share · traded 21 May 2020 · filed 22 May 2020
- exercised options over 6,054 shares of PERRIGO Co (a derivative holding)SEC Form 419 May 2020Restricted Stock Units · traded 15 May 2020 · filed 19 May 2020
- exercised options over 6,054 shares of PERRIGO CoSEC Form 419 May 2020Ordinary Shares · traded 15 May 2020 · filed 19 May 2020
- had shares withheld for tax on 2,906 shares of PERRIGO CoSEC Form 419 May 2020Ordinary Shares · traded 15 May 2020 · filed 19 May 2020
- was granted 3,728 shares of PpdSEC Form 415 May 2020Common stock · traded 13 May 2020 · filed 15 May 2020
- was granted 5,804 shares of PERRIGO Co (a derivative holding)SEC Form 411 May 2020Restricted Stock Units · traded 7 May 2020 · filed 11 May 2020
- was granted 62,189 shares of Precigen (a derivative holding)SEC Form 417 March 2020Restricted Stock Units · traded 13 March 2020 · filed 17 March 2020
- was granted 96,324 shares of Precigen (a derivative holding)SEC Form 417 March 2020Option to Purchase Common Stock (Right to Buy) · traded 13 March 2020 · filed 17 March 2020
- was granted 34,328 shares of PrecigenSEC Form 417 March 2020Common Stock · traded 13 March 2020 · filed 17 March 2020
- exercised options over 11,667 shares of vTv Therapeutics (a derivative holding)SEC Form 411 March 2020Restricted Stock Units · traded 10 March 2020 · filed 11 March 2020
- exercised options over 11,667 shares of vTv TherapeuticsSEC Form 411 March 2020Class A Common Stock · traded 10 March 2020 · filed 11 March 2020
- exercised options over 24,703 shares of Precigen (a derivative holding)SEC Form 410 March 2020Restricted Stock Units · traded 8 March 2020 · filed 10 March 2020
- exercised options over 24,703 shares of PrecigenSEC Form 410 March 2020Common Stock · traded 8 March 2020 · filed 10 March 2020
- returned to the issuer 93,595 shares of PpdSEC Form 412 February 2020Non-voting common stock · traded 10 February 2020 · filed 12 February 2020
- was granted 93,595 shares of PpdSEC Form 412 February 2020Common stock · traded 10 February 2020 · filed 12 February 2020
- ▲ bought on the open market 18,500 shares of PpdSEC Form 412 February 2020Common stock · traded 10 February 2020 · filed 12 February 2020
- was granted 35,000 shares of vTv Therapeutics (a derivative holding)SEC Form 43 December 2019Director stock option (right to buy) · traded 29 November 2019 · filed 3 December 2019
- was granted 15,000 shares of Siga Technologies (a derivative holding)SEC Form 422 May 2019Restricted Stock Units · traded 21 May 2019 · filed 22 May 2019
- exercised options over 15,000 shares of Siga Technologies (a derivative holding)SEC Form 422 May 2019Restricted Stock Units · traded 22 May 2019 · filed 22 May 2019
- exercised options over 15,000 shares of Siga TechnologiesSEC Form 422 May 2019Common Stock, Par Value $.0001 Per Share · traded 22 May 2019 · filed 22 May 2019
- was granted 6,054 shares of PERRIGO Co (a derivative holding)SEC Form 417 May 2019Restricted Stock Units · traded 15 May 2019 · filed 17 May 2019
- exercised options over 3,971 shares of PERRIGO Co (a derivative holding)SEC Form 417 May 2019Restricted Stock Units · traded 15 May 2019 · filed 17 May 2019
- exercised options over 3,971 shares of PERRIGO CoSEC Form 417 May 2019Ordinary Shares · traded 15 May 2019 · filed 17 May 2019
- had shares withheld for tax on 1,907 shares of PERRIGO CoSEC Form 417 May 2019Ordinary Shares · traded 15 May 2019 · filed 17 May 2019
- exercised options over 7,911 shares of Intrexon (a derivative holding)SEC Form 426 March 2019Restricted Stock Units · traded 23 March 2019 · filed 26 March 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.